Multicenter Study Assessing the Efficacy & Safety of Hydroxychloroquine Sulfate in Patients With Systemic Lupus Erythematosus or Cutaneous Lupus Erythematosus With Active Lupus Erythematosus Specific Skin Lesion

NCT01551069 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

103

Enrollment

INDUSTRY

Sponsor class

Conditions

Cutaneous Lupus Erythematosus-Systemic Lupus Erythematosus

Interventions

DRUG: hydroxychloroquine (Z0188)
DRUG: Placebo

Sponsor

Sanofi